India News | Press Trust of India | Monday November 1, 2021
Biotechnology firm Novavax Inc and its partner Serum Institute of India on Monday said they have received the first emergency use authorisation (EUA) for Novavax''s COVID-19 vaccine, in Indonesia.
www.ndtv.com